Frontlight ResearchEarly access
Colorectal cancer trials in United States
551 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Austin, Bedford, Boston, Charleston, Cleveland, Dallas, Denver, Detroit, Durham, Fairfax, Houston, Irvine, La Jolla, Los Angeles, Madison, Miami, Nashville, Newark, New Haven, New York, Oklahoma City, Orlando, Philadelphia, Pittsburgh, Port Charlotte, Portland, San Antonio, Seattle, York
- Age
- 12 years and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - No phaseTaking peopleColonoscopy vs Stool Testing for Older Adults With Colon Polyps
- Where
- Ann Arbor, Aurora, Birmingham, Charlotte, Charlottesville, Chicago, Detroit, Indianapolis, Lebanon, New York, Portand, Portland, Salt Lake City, San Diego, Sandy City, St Louis, Tampa, Tucson, Walnut Creek, Washington D.C.
- Age
- 65 years to 82 years
- People
- 6,434 worldwide
- Run by
- Dartmouth-Hitchcock Medical Center
See details and how to joinNCT05612347 - Phase 2Taking peopleComparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 50
- Run by
- Mayo Clinic
See details and how to joinNCT06265285 - No phaseNot yet taking people in United StatesPreventing Early-Onset Colorectal Cancer in the VA
- Where
- New York
- Age
- 45 years to 49 years
- People
- 536
- Run by
- VA Office of Research and Development
See details and how to joinNCT07071454 - Phase 2Taking peopleImmunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer
- Where
- Atlanta, Johns Creek
- Age
- 18 years and over
- People
- 40
- Run by
- Emory University
See details and how to joinNCT07140679 - Phase 1Taking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Austin, Baltimore, Boston, Celebration, Charlottesville, Chicago, Cleveland, Dallas, Detroit, Durham, East Brunswick, Gainesville, Hackensack, Hershey, Indianapolis, Irving, Jacksonville, Las Vegas, Littleton, Louisville, Miami, Milwaukee, Myrtle Beach, Nashville, Newark, New Haven, New York, Omaha, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Plano, Plantation, Portland, Rochester, Santa Barbara, Syracuse, Tampa, Tucson, Tyler
- Age
- 18 years and over
- People
- 1,394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - Phase 1Taking peopleOpen-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Where
- Boston, Dallas, Duarte, Houston, Indianapolis, Kansas City, Los Angeles, Madison, Nashville, New York, San Antonio, San Diego, San Francisco, Seattle, St Louis, Tampa
- Age
- 18 years and over
- People
- 392 worldwide
- Run by
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
See details and how to joinNCT06625775 · EU 2024-519445-29-00 - Phase 1/2Taking people177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- Where
- Dothan, Grand Rapids, Houston, Omaha
- Age
- 18 years and over
- People
- 61
- Run by
- Radiopharm Theranostics, Ltd
See details and how to joinNCT07189871 - Phase 1Taking peopleTLR9 Immunotherapy for Peritoneal Carcinomatosis
- Where
- Providence
- Age
- 18 years and over
- People
- 24
- Run by
- Brown University
See details and how to joinNCT07658196 - Phase 2Not yet taking people in United StatesA Study of Trastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 27
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07691489 - Phase 1/2Taking peoplePRE-ISPY Phase I/II Oncology Platform Program
- Where
- Aurora, Birmingham, Chicago, Houston, Minneapolis, New Lenox, Orland Park, Phoenix, Rochester, Tampa
- Age
- 18 years and over
- People
- 280
- Run by
- QuantumLeap Healthcare Collaborative
See details and how to joinNCT05868226 - No phaseTaking peopleThe Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
- Where
- Boston
- Age
- 18 years and over
- People
- 40
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06565052 - Phase 1Taking peopleA First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- Where
- Columbus, Fairfax, Farmington Hills, Grand Rapids, Houston, La Jolla, Morristown, Portland, Santa Monica, Spokane, Tampa, West Valley City
- Age
- 18 years and over
- People
- 170
- Run by
- ALX Oncology Inc.
See details and how to joinNCT07085091 - Phase 2Taking peopleThe Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 27
- Run by
- Mayo Clinic
See details and how to joinNCT07285044 - Phase 1Taking peopleA Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Where
- Boston, Charlotte, Duarte, Gilbert, Houston, Jacksonville, Los Angeles, Miami, Milwaukee, Nashville, New Brunswick, Newport Beach, New York, Pittsburgh, Portland, Round Rock, Santa Monica, Tampa, Winston-Salem
- Age
- 18 years and over
- People
- 45
- Run by
- AstraZeneca
See details and how to joinNCT05877599 - Phase 1Taking peopleA Study of PHN-012 in Patients With Advanced Solid Tumors
- Where
- Boston, Durham, Fairfax, Houston, Los Angeles, Nashville, Portland, San Antonio, San Diego, St Louis, Washington D.C.
- Age
- 18 years and over
- People
- 165 worldwide
- Run by
- Pheon Therapeutics
See details and how to joinNCT07127874 - Phase 2Taking peopleTesting the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial
- Where
- Houston, New Orleans
- Age
- 18 years and over
- People
- 20
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07551596 - Phase 1/2Taking peopleSpevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
- Where
- Boston, Denver, Duarte, Durham, Fairfax, Houston, Iowa City, Los Angeles, Louisville, Madison, Pittsburgh
- Age
- 18 years and over
- People
- 350
- Run by
- Phanes Therapeutics
See details and how to joinNCT05482893 - Phase 2Taking peopleOpen-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 33
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06369259 - Phase 1Taking peopleA Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
- Where
- Dallas, Nashville, New Hyde Park, Philadelphia, Reunion
- Age
- 18 years and over
- People
- 83 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07277270 · EU 2025-522274-37-00 - Phase 1Not yet taking people in United StatesCCR5 Targeting Leronlimab in Combination With Hepatic Arterial Infusion Floxuridine and Systemic Therapy for the Treatment of Colorectal Cancer Liver Metastases, CHAMP Trial
- Where
- Duarte, Goodyear, Irvine
- Age
- 18 years and over
- People
- 36
- Run by
- City of Hope Medical Center
See details and how to joinNCT07842965 - Phase 1/2Taking peopleSafety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Where
- Beverly Hills, Boston, Boynton Beach, Dallas, Glendale, Los Angeles, Nashville, Tacoma
- Age
- 18 years and over
- People
- 134
- Run by
- Neonc Technologies, Inc.
See details and how to joinNCT06047379 - Phase 1Taking peopleA Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Where
- New Have, Santa Monica
- Age
- 18 years and over
- People
- 76 worldwide
- Run by
- Kivu Bioscience Inc.
See details and how to joinNCT07229313 - Phase 2Taking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Albuquerque, Boston, Cincinnati, Columbus, Commack, East Brunswick, Grand Rapids, Houston, Kansas City, Los Angeles, Madison, Muncie, Nashville, Portland, San Diego, Santa Rosa
- Age
- 18 years to 130 years
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - No phaseTaking peoplePrecise Oncology Interventions in Nutrition and Training (OnPoint)
- Where
- Miami
- Age
- 18 years and over
- People
- 306
- Run by
- University of Miami
See details and how to joinNCT06534918